Cambridge Investment Research Advisors’s IQVIA IQV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.82M | Buy |
40,470
+7,455
| +23% | +$1.3M | 0.02% | 794 |
|
|
2026
Q1 | $5.63M | Buy |
33,015
+716
| +2% | +$140K | 0.01% | 898 |
|
|
2025
Q4 | $7.28M | Sell |
32,299
-523
| -2% | -$114K | 0.02% | 731 |
|
|
2025
Q3 | $6.23M | Buy |
32,822
+920
| +3% | +$167K | 0.02% | 786 |
|
|
2025
Q2 | $5.03M | Buy |
31,902
+3,331
| +12% | +$501K | 0.02% | 851 |
|
|
2025
Q1 | $5.04M | Buy |
28,571
+38
| +0.1% | +$7.37K | 0.02% | 797 |
|
|
2024
Q4 | $5.61M | Buy |
28,533
+410
| +1% | +$86.5K | 0.02% | 744 |
|
|
2024
Q3 | $6.66M | Buy |
28,123
+5,004
| +22% | +$1.18M | 0.02% | 663 |
|
|
2024
Q2 | $4.89M | Buy |
23,119
+1,478
| +7% | +$336K | 0.02% | 767 |
|
|
2024
Q1 | $5.47M | Buy |
21,641
+618
| +3% | +$144K | 0.02% | 699 |
|
|
2023
Q4 | $4.86M | Sell |
21,023
-586
| -3% | -$120K | 0.02% | 718 |
|
|
2023
Q3 | $4.25M | Sell |
21,609
-226
| -1% | -$49.1K | 0.02% | 732 |
|
|
2023
Q2 | $4.91M | Buy |
21,835
+1,077
| +5% | +$216K | 0.02% | 670 |
|
|
2023
Q1 | $4.13M | Sell |
20,758
-598
| -3% | -$128K | 0.02% | 734 |
|
|
2022
Q4 | $4.38M | Buy |
21,356
+272
| +1% | +$55.2K | 0.02% | 661 |
|
|
2022
Q3 | $3.82M | Sell |
21,084
-66
| -0.3% | -$14.5K | 0.02% | 686 |
|
|
2022
Q2 | $4.59M | Sell |
21,150
-672
| -3% | -$146K | 0.02% | 620 |
|
|
2022
Q1 | $5.04M | Sell |
21,822
-2,054
| -9% | -$486K | 0.02% | 628 |
|
|
2021
Q4 | $6.74M | Sell |
23,876
-383
| -2% | -$99.4K | 0.03% | 529 |
|
|
2021
Q3 | $5.81M | Sell |
24,259
-7,671
| -24% | -$1.94M | 0.03% | 547 |
|
|
2021
Q2 | $7.74M | Buy |
31,930
+382
| +1% | +$88.2K | 0.04% | 455 |
|
|
2021
Q1 | $6.09M | Sell |
31,548
-969
| -3% | -$182K | 0.03% | 499 |
|
|
2020
Q4 | $5.83M | Sell |
32,517
-13,178
| -29% | -$2.22M | 0.03% | 469 |
|
|
2020
Q3 | $7.2M | Buy |
45,695
+3,133
| +7% | +$491K | 0.05% | 350 |
|
|
2020
Q2 | $6.04M | Buy |
42,562
+5,782
| +16% | +$784K | 0.05% | 385 |
|
|
2020
Q1 | $3.97M | Buy |
36,780
+5,439
| +17% | +$777K | 0.04% | 437 |
|
|
2019
Q4 | $4.84M | Buy |
31,341
+1,457
| +5% | +$213K | 0.04% | 478 |
|
|
2019
Q3 | $4.46M | Buy |
29,884
+2,221
| +8% | +$346K | 0.04% | 460 |
|
|
2019
Q2 | $4.45M | Buy |
27,663
+3,323
| +14% | +$466K | 0.04% | 431 |
|
|
2019
Q1 | $3.5M | Buy |
24,340
+2,351
| +11% | +$313K | 0.03% | 499 |
|
|
2018
Q4 | $2.55M | Sell |
21,989
-111
| -0.5% | -$13.4K | 0.03% | 553 |
|
|
2018
Q3 | $2.87M | Buy |
22,100
+8,792
| +66% | +$1.06M | 0.03% | 556 |
|
|
2018
Q2 | $1.33M | Sell |
13,308
-1,072
| -7% | -$107K | 0.01% | 828 |
|
|
2018
Q1 | $1.41M | Buy |
14,380
+451
| +3% | +$45.6K | 0.02% | 769 |
|
|
2017
Q4 | $1.36M | Buy |
13,929
+112
| +0.8% | +$11.4K | 0.02% | 757 |
|
|
2017
Q3 | $1.31M | Buy |
13,817
+871
| +7% | +$80.7K | 0.02% | 710 |
|
|
2017
Q2 | $1.16M | Buy |
12,946
+1,531
| +13% | +$129K | 0.02% | 738 |
|
|
2017
Q1 | $919K | Buy |
+11,415
| New | +$891K | 0.02% | 764 |
|
Other funds holding IQV
Cambridge Investment Research Advisors's IQV Position: Q2 2026 in Review
Cambridge Investment Research Advisors increased its IQVIA (IQV) stake by 23% in Q2 2026, buying an estimated $1.3M and bringing the position to 40,470 shares worth $7.82M. The position accounts for 0.02% of the portfolio, ranked #794.
Cambridge Investment Research Advisors first reported a position in IQV in Q1 2017 and has held it in 38 quarters since. 1,085 funds tracked by Wall St. Rank hold IQV as of Q2 2026.
- Cambridge Investment Research Advisors held 40,470 shares of IQVIA worth $7.82M as of Q2 2026.
- Cambridge Investment Research Advisors bought 7,455 IQVIA shares in Q2 2026, an estimated $1.3M.
- IQVIA made up 0.02% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #794 holding.
- Cambridge Investment Research Advisors first reported a position in IQVIA in Q1 2017 and has held it in 38 quarters since.
- 1,085 funds tracked by Wall St. Rank held IQVIA as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.